Betamethasone dipropionate; calcipotriene - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for betamethasone dipropionate; calcipotriene and what is the scope of patent protection?
Betamethasone dipropionate; calcipotriene
is the generic ingredient in five branded drugs marketed by Glenmark Pharms Ltd, Leo Pharma As, MC2, Chartwell Rx, Padagis Israel, Cosette, and Taro, and is included in ten NDAs. There are ten patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Betamethasone dipropionate; calcipotriene has eighty-four patent family members in thirty-two countries.
Seven suppliers are listed for this compound.
Summary for betamethasone dipropionate; calcipotriene
International Patents: | 84 |
US Patents: | 10 |
Tradenames: | 5 |
Applicants: | 7 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 7 |
Clinical Trials: | 16 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for betamethasone dipropionate; calcipotriene |
DailyMed Link: | betamethasone dipropionate; calcipotriene at DailyMed |
Recent Clinical Trials for betamethasone dipropionate; calcipotriene
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alabama at Birmingham | Phase 4 |
Eli Lilly and Company | Phase 4 |
Celgene Corporation | Phase 4 |
See all betamethasone dipropionate; calcipotriene clinical trials